SYMPTOM MANAGEMENT FOR PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA RECEIVING THERAPY WITH SELINEXOR (XPOVIO (TM))

Florendo, E; Mancia, IS; Thomas, J

ONCOLOGY NURSING FORUM, 2020; 47 (2):